Clinical Trials Market: 2020 Global Sales, Size, Share, Competitive Analysis And Upcoming Opportunities

Clinical Trials Market Analysis

Global Clinical Trials Market Size is anticipated to expand at an impressive CAGR of 5.7% during the forecast period from 2017 to 2023. This growth is attributable to the increasing investment in the healthcare industry, especially on the research and development of newer drugs and treatment in order to cater to the rising need for newer technologies globally. The clinical trials are the research study, which conducts the safety and efficacy test of the new drug. These trails are conducted for testing the wide-ranging drugs and medical devices.

The market growth is primarily relied on the key factors, including the increasing prevalence of chronic and long-term diseases coupled with increasing investment in the R&D sector globally. In addition to this, industrialization has led to increased disposable income, globalization, and increased awareness about the health and availability of several key and important drugs. These factors are driving growth of the global clinical trials market. However, lack of a skilled and trained workforce is restraining growth of the global clinical trials market. Also, high cost, stringent regulations, and unfavorable government policies are hampering growth of the global clinical trials market.

Nonetheless, factors such as the introduction of newer treatments, including innovation in technologies, personalized medicine, and rising demand for contract research organization (CROs) to conduct clinical trials, are likely to offer several opportunities for growth in the coming years. Further, the companies are increasingly adopting and accepting CROs for expansion of portfolio and drive innovations.

Clinical Trials Market Competitive Analysis:

Some of the major companies in the global clinical trials market include Charles River Laboratories, Quintiles IMS, Paraxel International Corporation, ICON plc, Eli Lilly and Company, SGS SA, Novo Nordisk A/S, Laboratory Corporation of America, Clinipace, and Pfizer.

Clinical Trials Market Segmentation:

The clinical trials market is segmented on phase, study design, indication, and end users.

By phase, the market is segmented into phase I, phase II, phase III, and phase IV.

By study design, the market is segmented into observational, interventional, and expanded access.

On the basis of indication, the market is segmented into pain management, autoimmune/inflammation, oncology, diabetes, central nervous system (CNS) condition, cardiovascular, obesity, and others.

Based on the end-user, the market is segmented into dental institutes and dental academic, dental hospitals & clinics, and research institutes.

Obtain Premium Research Report Details @ https://www.marketresearchfuture.com/reports/clinical-trials-market-7787

Clinical Trials Market Regional Analysis:

Regionally, the clinical trials market is segmented into the Americas, Asia Pacific, Europe, and Middle East & Africa. Of these, the Americas region is estimated to remain dominant in the global clinical trials market owing to the strong presence of several key players in the region. Furthermore, the strong presence of biotech companies, along with R&D units in the region are benefiting the market. Rising healthcare spending coupled with the presence of developed countries including the U.S. and Canada is fueling growth of the market.

Additionally, Europe is estimated to be on second-leading revenue share in the overall clinical trial market due to a surge in government support in terms of several policies; rising clinical trials across the private and government sector are enhancing the scope of the clinical trials market in the region. However, Asia Pacific is estimated to expand at the fastest CAGR during the forecast period owing to the presence of developing economies coupled with improving infrastructure in the region is also fueling growth of the global clinical trials market.

Clinical Trials Market 2023 – Size, Share, Growth, Statistics, Competitor Landscape, Key Players Analysis, Trends And Overview

Clinical Trials Market Overview

Clinical trials are medical investigations to used for research and testing purposes for the evaluation of the accuracy, efficiency, and effects of new medical treatments on human health.

According to a detailed report published by Market Research Future (MRFR), the global clinical trials market has been assessed to grow exponentially at a CAGR of 5.7% over the forecast period.

The global clinical trials market is expected to grow owing to influential factors such as the rising demand for clinical trials due to the global expansion of the healthcare sectors, increasing expenditure towards research and development of the pharmaceutical industry, growing prevalence of chronic diseases, and the focus on the treatment methods for rare diseases.

Clinical Trials Market Segmental Analysis

The global clinical trials market has been segmented based on phase, study design, indication, end users, and region.

Based on the phase, the market has been segmented into phase I, phase II, phase III, and phase IV. Among these, the phase III trial segment has been assessed to lead the market as the largest segment, owing to its high value in the healthcare sector, as well as its comparatively superior effectiveness. Phase I trial segment has been expected to grow at the fastest growth rate during the forecast period, owing to the increase in its applications in investigative new drug (IND) sector, technological advancements, and the rising government initiatives to improve the healthcare sector in emerging economies.

Based on the study design, the global clinical trials market has been segmented into expanded access interventional, and observational.

Based on indication, the global clinical trials market has been segmented into autoimmune/inflammation, cardiovascular, central nervous system (CNS) condition, diabetes, obesity, oncology, pain management, and others.

Based on the end-user, the clinical trials market is segmented into dental hospitals & clinics, dental institutes, and dental academic and research institutes.

Based on the region, the global clinical trials market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).

Clinical Trials Market Regional Analysis

The Americas have been assessed to dominate the global clinical trials market owing to the presence of multiple major pharmaceutical companies, rise in the patient population, and the increasing innovations towards product development. Additionally, the growing cases of patients suffering from chronic diseases such as cancer, diabetes, and other life-threatening diseases increases the demand for innovative drugs and contributes to the improvement of clinical trial methods to expand treatment options. These factors are also estimated to drive the clinical trials market in the region over the forecast period.

Europe has been identified as the second leading regional market for clinical trials, owing to factors such as an increase in the expenditure towards research and development in the pharmaceutical industry, and growing prevalence of chronic diseases is predictable to give a further boost to the clinical trial market. Additionally, favorable government regulations for clinical trials  further support the market growth in the region and increases the demand for new products across Europe, which will consequently lead to market growth over the forecast period.

The Asia Pacific region has been assessed as the fastest growing market  for clinical trials during the forecast period, owing to the increasing incidence of diseases, growing focus of the governments on developing medications for rare diseases and the growth in the export sector contributes substantially to the clinical trial market in the region. In countries like India, China, and Australia, the developing economy and low cost to operate clinical trial facilities supply the market growth in this region.

The Middle East & Africa has been estimated to witness slow, gradual growth in the global clinical trials market over the forecast period, owing to the presence of weak economies, lesser technical amenities, lack of medical knowledge, and limited clinical trials centers, especially in the African region decrease the market growth. The Middle East has been expected to contribute the majority of the market share in this region, due to the presence of a well-established healthcare sector and huge healthcare expenditure by the governments of countries like Saudi Arabia, Kuwait, and Qatar.

Obtain Premium Research Report Details @ https://www.marketresearchfuture.com/reports/clinical-trials-market-7787

Clinical Trials Market Key players

The key players identified in the global clinical market are Charles River Laboratories, Clinipace, Eli Lilly and Company, ICON plc, Laboratory Corporation of America, Novo Nordisk A/S, Paraxel International Corporation, Pfizer, Quintiles IMS, SGS SA, among others.